{"id":54567,"date":"2023-03-07T12:05:21","date_gmt":"2023-03-07T11:05:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/"},"modified":"2023-03-07T12:05:21","modified_gmt":"2023-03-07T11:05:21","slug":"axonics-to-participate-in-the-sufu-2023-winter-meeting","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/","title":{"rendered":"Axonics to Participate in the SUFU 2023 Winter Meeting"},"content":{"rendered":"<div>\n<p>IRVINE, Calif.&#8211;(BUSINESS WIRE)&#8211;Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is participating as a platinum sponsor of the Society of Urodynamics, Female Pelvic Medicine &amp; Urogenital Reconstruction (SUFU) 2023 Winter Meeting, which is being held in Nashville from March 7-11.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230307005376\/en\/788134\/5\/Axonics_Logo_-_Color.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230307005376\/en\/788134\/21\/Axonics_Logo_-_Color.jpg\"><\/a><\/p>\n<p>\nAxonics is sponsoring a symposium on Friday, March 10, titled \u201cEmerging Clinical Evidence for Axonics SNM Therapy.\u201d During the symposium, a panel of physicians will discuss the results of the ARTSTRY registry study, which explores real world outcomes with Axonics sacral neuromodulation (SNM) therapy for patients with overactive bladder, urinary retention and fecal incontinence.\n<\/p>\n<p>\nIn addition, data highlighting the experience of patients with Axonics SNM therapy will include three poster presentations:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<i>The Role of Age in the Effectiveness of SNM for OAB<\/i> \u2013 presented by Ayman Mahdy, M.D., Ph.D.\n<\/li>\n<li>\n<i>Effectiveness of the Axonics SNM System in Improving Sleep Quality of Life for Patients Suffering with Nocturia<\/i> \u2013 presented by Michael Kennelly, M.D.\n<\/li>\n<li>\n<i>Efficacy and Durability of the Predictive Programming Algorithm of the Axonics SNM System<\/i> \u2013 presented by Ryan Krlin, M.D.\n<\/li>\n<\/ul>\n<p>\n\u201cThe SUFU 2023 Winter Meeting provides an opportunity for physicians to learn more about Axonics SNM therapy and the durable symptom relief patients are experiencing, directly from their peers,\u201d said Karen Noblett, M.D., chief medical officer of Axonics. \u201cWe remain focused on the Axonics mission of improving the quality of life for adults with incontinence and as such, clinical efficacy and the patient experience continue to be our north star. We are confident that thoughtful innovation coupled with increased public awareness has the potential to significantly increase the adoption of advanced therapies in the years ahead.\u201d\n<\/p>\n<p>\n<b>About Axonics<sup>\u00ae<\/sup><\/b>\n<\/p>\n<p>\nAxonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 1 on the 2022 <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ft.com%2Fcontent%2F6ee8f978-a2e0-4644-b7c7-0718a334adb7&amp;esheet=53357231&amp;newsitemid=20230307005376&amp;lan=en-US&amp;anchor=Financial+Times&amp;index=1&amp;md5=14fc9230faedc7745e20f09e30ad4039\" rel=\"nofollow noopener\" shape=\"rect\">Financial Times<\/a> ranking of the 500 fastest growing companies in the Americas and No. 4 on the 2022 <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fdeloitte-unveils-2022-north-america-technology-fast-500-rankings-301679342.html&amp;esheet=53357231&amp;newsitemid=20230307005376&amp;lan=en-US&amp;anchor=Deloitte&amp;index=2&amp;md5=981dd2ae228d84519af7b0ca6782a131\" rel=\"nofollow noopener\" shape=\"rect\">Deloitte<\/a> Technology Fast 500\u2122 following its No. 1 ranking in 2021.\n<\/p>\n<p>\nAxonics sacral neuromodulation systems provide adults with overactive bladder and\/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company\u2019s best-in-class urethral bulking hydrogel, Bulkamid<sup>\u00ae<\/sup>, provides safe and durable symptom relief to women with stress urinary incontinence. In the U.S., moderate to severe urinary incontinence affects an estimated 28 million women and fecal incontinence affects an estimated 19 million adults. Axonics\u2019 clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.axonics.com&amp;esheet=53357231&amp;newsitemid=20230307005376&amp;lan=en-US&amp;anchor=www.axonics.com&amp;index=3&amp;md5=7112ef3f7a6dd2a0c37abe04ad584756\" rel=\"nofollow noopener\" shape=\"rect\">www.axonics.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Axonics contact<\/b>:<br \/>\n<br \/>Neil Bhalodkar<br \/>\n<br \/>949-336-5293<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x69;&#x72;&#x40;&#x61;&#x78;&#x6f;&#x6e;&#105;&#99;&#115;&#46;&#99;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">I&#82;&#64;&#x61;&#x78;o&#110;&#105;&#x63;&#x73;&#x2e;c&#111;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>IRVINE, Calif.&#8211;(BUSINESS WIRE)&#8211;Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is participating as a platinum sponsor of the Society of Urodynamics, Female Pelvic Medicine &amp; Urogenital Reconstruction (SUFU) 2023 Winter Meeting, which is being held in Nashville from March &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54567","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Axonics to Participate in the SUFU 2023 Winter Meeting - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Axonics to Participate in the SUFU 2023 Winter Meeting - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"IRVINE, Calif.&#8211;(BUSINESS WIRE)&#8211;Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is participating as a platinum sponsor of the Society of Urodynamics, Female Pelvic Medicine &amp; Urogenital Reconstruction (SUFU) 2023 Winter Meeting, which is being held in Nashville from March ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-07T11:05:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230307005376\/en\/788134\/21\/Axonics_Logo_-_Color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-to-participate-in-the-sufu-2023-winter-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-to-participate-in-the-sufu-2023-winter-meeting\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Axonics to Participate in the SUFU 2023 Winter Meeting\",\"datePublished\":\"2023-03-07T11:05:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-to-participate-in-the-sufu-2023-winter-meeting\\\/\"},\"wordCount\":463,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-to-participate-in-the-sufu-2023-winter-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230307005376\\\/en\\\/788134\\\/21\\\/Axonics_Logo_-_Color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-to-participate-in-the-sufu-2023-winter-meeting\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-to-participate-in-the-sufu-2023-winter-meeting\\\/\",\"name\":\"Axonics to Participate in the SUFU 2023 Winter Meeting - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-to-participate-in-the-sufu-2023-winter-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-to-participate-in-the-sufu-2023-winter-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230307005376\\\/en\\\/788134\\\/21\\\/Axonics_Logo_-_Color.jpg\",\"datePublished\":\"2023-03-07T11:05:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-to-participate-in-the-sufu-2023-winter-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-to-participate-in-the-sufu-2023-winter-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-to-participate-in-the-sufu-2023-winter-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230307005376\\\/en\\\/788134\\\/21\\\/Axonics_Logo_-_Color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230307005376\\\/en\\\/788134\\\/21\\\/Axonics_Logo_-_Color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-to-participate-in-the-sufu-2023-winter-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Axonics to Participate in the SUFU 2023 Winter Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Axonics to Participate in the SUFU 2023 Winter Meeting - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Axonics to Participate in the SUFU 2023 Winter Meeting - Pharma Trend","og_description":"IRVINE, Calif.&#8211;(BUSINESS WIRE)&#8211;Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is participating as a platinum sponsor of the Society of Urodynamics, Female Pelvic Medicine &amp; Urogenital Reconstruction (SUFU) 2023 Winter Meeting, which is being held in Nashville from March ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-07T11:05:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230307005376\/en\/788134\/21\/Axonics_Logo_-_Color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Axonics to Participate in the SUFU 2023 Winter Meeting","datePublished":"2023-03-07T11:05:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/"},"wordCount":463,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230307005376\/en\/788134\/21\/Axonics_Logo_-_Color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/","url":"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/","name":"Axonics to Participate in the SUFU 2023 Winter Meeting - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230307005376\/en\/788134\/21\/Axonics_Logo_-_Color.jpg","datePublished":"2023-03-07T11:05:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230307005376\/en\/788134\/21\/Axonics_Logo_-_Color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230307005376\/en\/788134\/21\/Axonics_Logo_-_Color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/axonics-to-participate-in-the-sufu-2023-winter-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Axonics to Participate in the SUFU 2023 Winter Meeting"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54567"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54567\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}